Analytical issues regarding rosiglitazone meta-analysis

Arch Intern Med. 2011 Jan 24;171(2):179-80; author reply 180. doi: 10.1001/archinternmed.2010.508.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cardiovascular Diseases / chemically induced
  • Cardiovascular Diseases / mortality
  • Data Interpretation, Statistical
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Hypoglycemic Agents / therapeutic use
  • Meta-Analysis as Topic
  • Myocardial Infarction / chemically induced*
  • Myocardial Infarction / mortality
  • Rosiglitazone
  • Thiazolidinediones / adverse effects*
  • Thiazolidinediones / therapeutic use

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Rosiglitazone